Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 246
- +29 vs. Q3 2025
- Shares held
- 44.1M
- −761.0K (−1.7%) vs. Q3 2025
- Total value
- $3.61B
- +$943.5M (+35.4%) vs. Q3 2025
- New holders
- 52
- 84 more added
- Sold out
- 23
- 85 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 119,058 | $9.75M | 0.00% | +20,307+20.6% | Added |
| Jump Financial, LLC | 128,087 | $10.5M | 0.13% | −137,918−51.8% | Reduced |
| Allspring Global Investments Holdings, LLC | 130,380 | $10.5M | 0.02% | +1,643+1.3% | Added |
| Canada Pension Plan Investment Board | 151,100 | $12.4M | 0.01% | +19,800+15.1% | Added |
| Russell Investments Group, Ltd. | 153,760 | $12.6M | 0.01% | +5,431+3.7% | Added |
| OrbiMed Advisors LLC | 154,400 | $12.6M | 0.26% | −43,500−22.0% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 161,830 | $13.3M | 0.02% | +61,830+61.8% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 173,275 | $14.2M | 0.04% | +69,464+66.9% | Added |
| Integral Health Asset Management, LLC | 200,000 | $16.4M | 0.83% | −50,000−20.0% | Reduced |
| Cormorant Asset Management, LP | 250,000 | $20.5M | 1.16% | −50,000−16.7% | Reduced |
| Rock Springs Capital Management LP | 260,344 | $21.3M | 1.09% | −28,000−9.7% | Reduced |
| Nuveen, LLC | 322,527 | $26.4M | 0.01% | −8,153−2.5% | Reduced |
| MPM Oncology Impact Management LP | 328,869 | $26.9M | 3.08% | −12,627−3.7% | Reduced |
| TimesSquare Capital Management, LLC | 332,446 | $27.2M | 0.41% | +64,941+24.3% | Added |
| Charles Schwab Investment Management Inc | 333,111 | $27.3M | 0.00% | +199+0.1% | Added |
| Franklin Resources Inc | 337,016 | $27.6M | 0.01% | +314,833+1,419.3% | Added |
| Northern Trust Corp | 342,486 | $28.0M | 0.00% | −15,616−4.4% | Reduced |
| BNP Paribas Arbitrage, SA | 356,105 | $29.2M | 0.02% | +151,805+74.3% | Added |
| Goldman Sachs Group Inc | 378,704 | $31.0M | 0.00% | +37,692+11.1% | Added |
| Qube Research & Technologies Ltd | 401,241 | $32.9M | 0.05% | −121,035−23.2% | Reduced |
| Artisan Partners Limited Partnership | 436,576 | $35.7M | 0.05% | −121,750−21.8% | Reduced |
| Loomis Sayles & Co L P | 441,873 | $36.2M | 0.04% | +51,972+13.3% | Added |
| Ensign Peak Advisors, Inc | 474,050 | $38.8M | 0.07% | −8,314−1.7% | Reduced |
| Clearbridge Investments, LLC | 506,089 | $41.4M | 0.03% | −60,889−10.7% | Reduced |
| Toronto Dominion Bank | 510,253 | $41.8M | 0.07% | −107,330−17.4% | Reduced |
| Price T Rowe Associates Inc | 518,780 | $42.5M | 0.00% | +65,923+14.6% | Added |
| Nomura Asset Management International Inc. | 584,686 | $47.9M | 0.07% | +584,686 | New |
| D. E. Shaw & Co., Inc. | 615,156 | $50.4M | 0.04% | +16,849+2.8% | Added |
| FMR LLC | 647,114 | $53.0M | 0.00% | +625,253+2,860.1% | Added |
| Frazier Life Sciences Management, L.P. | 728,644 | $59.7M | 1.60% | −438,883−37.6% | Reduced |
| Bank of America Corp | 758,106 | $62.1M | 0.00% | +222,083+41.4% | Added |
| Lord, Abbett & Co. LLC | 855,645 | $70.1M | 0.21% | −129,984−13.2% | Reduced |
| State Street Corp | 929,059 | $76.1M | 0.00% | −7,103−0.8% | Reduced |
| Geode Capital Management, LLC | 947,763 | $77.6M | 0.00% | +3,267+0.3% | Added |
| Invesco Ltd. | 1,012,357 | $82.9M | 0.01% | +75,351+8.0% | Added |
| Assenagon Asset Management S.A. | 1,127,730 | $92.3M | 0.14% | −120,224−9.6% | Reduced |
| Driehaus Capital Management LLC | 1,172,427 | $96.0M | 0.65% | +141,386+13.7% | Added |
| Tang Capital Management LLC | 1,188,624 | $97.3M | 4.81% | −1,266,173−51.6% | Reduced |
| Janus Henderson Group PLC | 1,930,325 | $158.1M | 0.07% | +491,326+34.1% | Added |
| Morgan Stanley | 2,040,742 | $167.1M | 0.01% | +128,340+6.7% | Added |
| Jennison Associates LLC | 2,230,069 | $182.6M | 0.11% | −374,511−14.4% | Reduced |
| Vanguard Group Inc | 2,399,560 | $196.5M | 0.00% | +127,470+5.6% | Added |
| Paradigm Biocapital Advisors LP | 2,562,154 | $209.8M | 5.62% | −103,544−3.9% | Reduced |
| Deep Track Capital, LP | 3,004,034 | $246.0M | 5.61% | +4,034+0.1% | Added |
| RTW Investments, LP | 3,335,320 | $273.1M | 2.74% | +157,884+5.0% | Added |
| BlackRock, Inc. | 3,790,557 | $310.4M | 0.01% | +10,936+0.3% | Added |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −833,437−100.0% | Sold out |
| Polygon Management Ltd. | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −119,260−100.0% | Sold out |
| Capitolis Liquid Global Markets LLC | 0 | $0 | 0.00% | −102,600−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −91,171−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −70,778−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −51,678−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −43,281−100.0% | Sold out |
| RFG Advisory, LLC | 0 | $0 | 0.00% | −14,941−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −12,593−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −11,501−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −11,211−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −7,627−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −7,218−100.0% | Sold out |
| Nations Financial Group Inc, | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −5,494−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −5,062−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −3,521−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,163−100.0% | Sold out |
| Crowley Wealth Management, Inc. | 0 | $0 | 0.00% | −450−100.0% | Sold out |
| Catherine Avery Investment Management LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| CIBC Bancorp USA Inc. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |